Yes, vinorelbine is often used in combination with other chemotherapeutic agents, immunotherapies, or targeted therapies to enhance its efficacy. For instance, in the treatment of NSCLC, vinorelbine is frequently combined with platinum-based agents like cisplatin or carboplatin. Combination therapy can improve response rates and survival outcomes.
